Details for 2003737365

Up to date per 19.05.2026

Actions

Title / Product Name

Pharmazeutische Formulierung enthaltend eine wässrige Suspension eines Androstan-Derivats zur Behandlung von entzündlichen und allergischen Zuständen

Status

Deleted

Protection Type

European Patent

(AT-) Application Number

2003737365

EP Publication Number

1478340

E-Number

1039732

Language

PCT Number

GB03000504

Publication Date

24.11.2004 A

12.09.2018 B1

Registration Date

12.09.2018

AT Publication Date

15.10.2018

Application Date

04.02.2003

Registration Number

Priorities

04.02.2002

67020

IPC

A61K 9/00 20060101AFI20180306BHEP

Maximum Duration of Protection

04.02.2023

Owner

Glaxo Group Limited980 Great West Road Brentford, Middlesex TW8 9GSGB

Representative

No representatives present

Inventor

BIGGADIKE, KeithGlaxoSmithKline, Gunnels Wood Road Stevenage, Hertfordshire SG1 2NYGB

BUXTON, IanGlaxoSmithKline Inc., 7333 Mississauga Road North Mississauga, Ontario L5N 6L4CA

COOTE, Steven, JohnGlaxoSmithKline, Gunnels Wood Road Stevenage, Hertfordshire SG1 2NYGB

NICE, Rosalyn, KayGlaxoSmithKline, Gunnels Wood Road Stevenage, Hertfordshire SG1 2NYGB

REED, Kenton, LewisGlaxoSmithKline Inc., 7333 Mississauga Road North Mississauga, Ontario L5N 6L4CA

SAYANI, AmynGlaxoSmithKline Inc., 7333 Mississauga Road North Mississauga, Ontario L5N 6L4CA

SHARMA, Avinash, ChanderGlaxoSmithKline Inc., 7333 Mississauga Road North Mississauga, Ontario L5N 6L4CA